https://www.selleckchem.com/pr....oducts/tulmimetostat
Error grid analysis showed the proportions of measurements in risk zones A to E were 83.22%, 16.46%, 0.32%, 0%, and 0% for SBP, and 97.81%, 2.19%, 0%, 0%, and 0% for MAP, respectively. Intra-arterial MAP can be used reliably to monitor the effect of intravenous nicardipine for treating severe hypertension. Intra-arterial SBP may trigger moderate-risk treatment decisions in the women with oscillometric SBP≤160mm Hg. Intra-arterial MAP can be used reliably to monitor the effect of intravenous nicardipine for treating severe hyperten
Like
Comment
Share
